Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
46.44
0.00 (0.00%)
Jun 18, 2025, 4:00 PM - Market closed
Kymera Therapeutics Analyst Ratings
Total Analysts
16
Consensus Rating
Strong Buy
Price Target
$59.38
Upside
+27.86%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Hold → Strong Buy Upgrades $38 → $60 | Hold → Strong Buy | Upgrades | $38 → $60 | +29.20% | Jun 3, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $49 → $79 | Hold → Buy | Upgrades | $49 → $79 | +70.11% | Jun 3, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $57 → $64 | Buy | Maintains | $57 → $64 | +37.81% | Jun 3, 2025 |
| Stifel | Stifel | Strong Buy Initiates $55 | Strong Buy | Initiates | $55 | +18.43% | May 20, 2025 |
| UBS | UBS | Strong Buy Maintains $72 → $70 | Strong Buy | Maintains | $72 → $70 | +50.73% | May 13, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +11.97% | May 12, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $47 → $44 | Hold | Maintains | $47 → $44 | -5.25% | May 12, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $52 | Strong Buy | Initiates | $52 | +11.97% | Mar 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $54 → $60 | Strong Buy | Maintains | $54 → $60 | +29.20% | Feb 28, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $60 | Buy | Reiterates | $60 | +29.20% | Jan 21, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $60 | Buy | Maintains | $60 | +29.20% | Dec 27, 2024 |
| BTIG | BTIG | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +29.20% | Dec 10, 2024 |
| BMO Capital | BMO Capital | Hold Initiates $55 | Hold | Initiates | $55 | +18.43% | Dec 6, 2024 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $38 → $57 | Hold → Buy | Upgrades | $38 → $57 | +22.74% | Dec 2, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $65 | Buy | Initiates | $65 | +39.97% | Nov 18, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $45 → $49 | Hold | Maintains | $45 → $49 | +5.51% | Nov 6, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.